Diabetes
Doxycycline blocks enzyme activity to heal chronic diabetic ulcers
Published in Drug Week, March 26th, 2004
"Chronic diabetic ulcers are characterized by elevated levels of pro-inflammatory cytokines and proteases, which are thought to impair wound healing by degrading essential molecules. There is a need for an inexpensive, safe, and simple-to-use agent that promotes healing by selectively reducing levels of pro-inflammatory cytokines and proteases. Doxycycline, a member of the tetracycline family of antibiotics that inhibits metalloproteinases, was evaluated in vitro for inhibition of tumor necrosis factor-alpha (TNF-alpha) converting enzyme (TACE) and for inhibition of protease activities in human chronic...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2004-03-26)
More Articles from Drug Week
- Drug Development
Researchers ponder how to make drugs without side effects - Meningitis
CDC recommends suspension of third and fourth doses of Prevnar - Substance Abuse
Disulfiram, cognitive behavioral therapy appear effective for cocaine dependence - Vaccine Development
New vaccine eliminates IL-6 immune response - Virology
RNA molecules play important role as antiviral agents for cell treatment - Acne
FDA debates more restrictions on Accutane - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
